Premium
Costs of ALK , ROS1 , EGFR , and KRAS testing in non–small cell lung cancer: About different strategies in France
Author(s) -
Lambros Laetitia,
Guibourg Briac,
Uguen Arnaud
Publication year - 2017
Publication title -
cancer cytopathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.29
H-Index - 57
eISSN - 1934-6638
pISSN - 1934-662X
DOI - 10.1002/cncy.21919
Subject(s) - kras , ros1 , lung cancer , medicine , fluorescence in situ hybridization , crizotinib , cancer , oncology , anaplastic lymphoma kinase , adenocarcinoma , immunohistochemistry , cancer research , biology , gene , colorectal cancer , malignant pleural effusion , chromosome , biochemistry